Global Stem Cell Banking Market Overview
According to SPER Market Research, the Global Stem Cell Banking Market is estimated to reach USD 24.27 billion by 2032 with a CAGR of 15.82%.
Stem cell banking is the process of taking precious stem cells from the human body, processing them, and storing them in advance of potential use in stem cell therapies. In stem cell banks, low temperatures are utilised to preserve stem cells' biological properties and protect them against deterioration and contamination. Any stem cell bank that wants to store cells for longer periods of time without losing their qualities must follow standardised, quality-controlled preservation processes. Globally rising birth rates, stem cell application R&D initiatives, and an increase in the prevalence of life-threatening chronic diseases are all contributing to the market's growth. Additionally, a number of blood-related diseases and cancers can be treated with stem cells. Market expansion is also being driven by the demand for innovative medications to treat serious illnesses. The growth of stem cell banks as well as an increase in consumer health spending both contribute to market expansion.
Impact of COVID-19 on the Global Stem Cell Banking Market
On the market for stem cell banking, the COVID-19 epidemic is expected to have a detrimental effect. A significant public health problem was caused by the COVID-19 outbreak. To prevent the spread of the COVID-19 virus, the majority of stem cell collecting techniques were slowed down. However, the market expansion following the pandemic may be influenced by clinical trials for the use of stem cells for COVID-19 treatment. On the plus side, stem cell treatments for COVID-19 in clinical studies may help the industry recover quickly from the epidemic. The market will expand profitably as clinical trials including the use of stem cells are gradually increased.
Scope of the Report:
Report Metric | Details |
Market size available for years | 2019-2032 |
Base year considered | 2021 |
Forecast period | 2022-2032 |
Segments covered | By Service Type, By Utilization, By Cell Type, By Bank Type.
|
Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
|
Companies Covered | American CryoStem Corporation, Americord Registry LLC, Cordlife Group Limited, Cryo Cell International Inc., Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., StemCyte Cord Blood Bank, Covis Pharma, Global Cord Blood Corporation, Smart cells.
|
Global Stem Cell Banking Market Segmentation:
1. By Service Type:
- Analysis
- Collection & Transportation
- Processing
- Storage
2. By Utilization:
3. By Cell Type:
- Adult Stem Cell
- Cord Blood
- Cord Tissue
- Embryonic Stem Cell
- Placenta
- Umbilical Cord Stem Cell
4. By Bank Type:
5. By Region:
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- Latin America
Key Topics Covered in the Report:
- Size of Global Stem Cell Banking Market (FY’2019-FY’2032)
- Overview of Global Stem Cell Banking Market
- Segmentation of Global Stem Cell Banking Market By Service Type (Collection & Transportation, Processing, Analysis, and Storage)
- Segmentation of Global Stem Cell Banking MarketBy Utilization (Used and Unused)
- Segmentation of Global Stem Cell Banking Market By Cell Type (Umbilical Cord Stem Cell, Cord Blood, Cord Tissue, Placenta, Adult Stem Cell, and Embryonic Stem Cell)
- Segmentation of Global Stem Cell Banking MarketBy Bank Type (Public and Private)
- Statistical Snap of Global Stem Cell Banking Market
- Growth Analysis of Global Stem Cell Banking Market
- Problems and Challenges in Global Stem Cell Banking Market
- Competitive Landscape in the Global Stem Cell Banking Market
- Impact of COVID-19 and Demonetization on Global Stem Cell Banking Market
- Details on Recent Investment in Global Stem Cell Banking Market
- Competitive Analysis of Global Stem Cell Banking Market
- Major Players in the Global Stem Cell Banking Market
- SWOT Analysis of Global Stem Cell Banking Market
- Global Stem Cell Banking Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Stem Cell Banking Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Stem Cell Banking Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Stem Cell Banking Market
7. Global Stem Cell Banking Market, By Service Type, 2019-2032 (USD Million)
7.1 Analysis
7.2 Collection & Transportation
7.3 Processing
7.4 Storage
8. Global Stem Cell Banking Market, By Utilization, 2019-2032 (USD Million)
8.1 Used
8.2 Unused
9. Global Stem Cell Banking Market, By Cell Type,2019-2032 (USD Million)
9.1 Adult Stem Cell
9.2 Cord Blood
9.3 Cord Tissue
9.4 Embryonic Stem Cell
9.5 Placenta
9.6 Umbilical Cord Stem Cell
10. Global Stem Cell Banking Market, By Bank Type, 2019-2032 (USD Million)
10.1 Public
10.2 Private
11. Global Stem Cell Banking Market, By Region, 2019-2032 (USD Million)
11.1 Global Stem Cell Banking Market Size and Market Share by Region (2019-2025)
11.2 Global Stem Cell Banking Market Size and Market Share by Region (2026-2032)
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Europe
11.4.1 France
11.4.2 Germany
11.4.3 Italy
11.4.4 Spain
11.4.5 United Kingdom
11.4.6 Rest of Europe
11.5 Middle East and Africa
11.5.1 Kingdom of Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 Rest of Middle East & Africa
11.6 North America
11.6.1 Canada
11.6.2 Mexico
11.6.3 United States
11.7 Latin America
11.7.1 Argentina
11.7.2 Brazil
11.7.3 Rest of Latin America
12.Company Profiles
12.1 American CryoStem Corporation
12.1.1 Company details
12.1.2 Financial outlook
12.1.3 Product summary
12.1.4 Recent developments
12.2 Americord Registry LLC
12.2.1 Company details
12.2.2 Financial outlook
12.2.3 Product summary
12.2.4 Recent developments
12.3 Cordlife Group Limited
12.3.1 Company details
12.3.2 Financial outlook
12.3.3 Product summary
12.3.4 Recent developments
12.4 Cryo Cell International Inc
12.4.1 Company details
12.4.2 Financial outlook
12.4.3 Product summary
12.4.4 Recent developments
12.5 Cryoholdco De LatinoAmerica
12.5.1 Company details
12.5.2 Financial outlook
12.5.3 Product summary
12.5.4 Recent developments
12.6 S.A.P.I. DE C.V
12.6.1 Company details
12.6.2 Financial outlook
12.6.3 Product summary
12.6.4 Recent developments
12.7 StemCyte Cord Blood Bank
12.7.1 Company details
12.7.2 Financial outlook
12.7.3 Product summary
12.7.4 Recent developments
12.8 Covis Pharma
12.8.1 Company details
12.8.2 Financial outlook
12.8.3 Product summary
12.8.4 Recent developments
12.9 Global Cord Blood Corporation
12.9.1 Company details
12.9.2 Financial outlook
12.9.3 Product summary
12.9.4 Recent developments
12.10 Smart cells
12.10.1 Company details
12.10.2 Financial outlook
12.10.3 Product summary
12.10.4 Recent developments
13.List of Abbreviations
14.Reference Links
15.Conclusion
16.Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.